Tim Schlidt

Partner, Palo Santo

Tim brings extensive knowledge of investing across life sciences and healthcare services, and has held a lifelong passion for understanding and improving treatments for CNS disorders. 

He believes psychedelics are poised to shift the paradigm in mental health treatment and his primary mission in co-funding Palo Santo is to invest in companies and solutions that allow for broad access to those most in need of mental health care. 

Prior to co-founding Palo Santo, Tim covered the life sciences and health care services sectors as a private equity investor at Madison Dearborn Partners and an investment banker at J.P. Morgan and Greenhill.